Bonac Corporation (“Bonac”; HQ: Kurume City, Fukuoka; CEO: Hirotake Hayashi) is pleased to announce the signing of a comprehensive research collaboration agreement with Kurume University, with the aim of contributing to the development of medicine and healthcare, through collaboration and cooperation in the field of next-generation drug discovery research and development.

 

On July 28, CEO Hirotake Hayashi and President Kensei Nagata of Kurume University visited Kurume City Hall and signed the agreement in the presence of Kurume Mayor Toshinori Narahara.

 

This event was introduced in TVQ Kyushu Broadcasting's "Look Up Fukuoka" broadcast from 5:13 p.m. to 5:25 p.m. on July 28.

 

With the conclusion of this agreement, Bonac will further promote the research and development of next-generation drug discovery, including nucleic acid medicine, in the Kurume region through industry-academia collaboration by combining our research know-how with the academic research functions of Kurume University.

 

Contact:

Corporate Affairs

press@bonac.co.jp

From left, Kensei Nagata, President of Kurume University; Hirotake Hayashi, CEO of Bonac; Toshinori Narahara, Governor of Kurume City